China developing 'gene-edited super soldiers' in biological warfare revolution: https://www.dailystar.co.uk/news/latest-news/china-developing-gene-edited-super-20546721
China’s Military Biotech Frontier: CRISPR, Military-Civil Fusion, and the New Revolution in Military Affairs: https://jamestown.org/program/chinas-military-biotech-frontier-crispr-military-civil-fusion-and-the-new-revolution-in-military-affairs/
China’s national strategy of military-civil fusion (军民融合, junmin ronghe) has highlighted biology as a priority. It is hardly surprising that the People’s Republic of China (PRC) is looking to leverage synergies among defense, scientific, and commercial developments in biological interdisciplinary (生物交叉, shengwu jiaocha) technologies. Chinese military scientists and strategists have consistently emphasized that biotechnology could become a “new strategic commanding heights of the future Revolution in Military Affairs” (军事革命, junshi geming)
A doctoral dissertation titled “Evaluation and Research on Human Performance Enhancement Technology,” published in 2016, envisions CRISPR as one of three primary “human performance enhancement technologies” (人效能增强技术, ren xiaoneng zengqiang jishu) that can be utilized to boost personnel combat effectiveness.
Ultimately, today’s advances in biotechnology may prove revolutionary, and the strategic implications, whether for medicine or the military or aggregate national competitiveness, are only just starting to be appreciated.  Today, the PRC is actively exploring new frontiers of such biological cross-disciplinary technologies: from these prominent developments in CRISPR to bionic robotics, intelligentized exoskeletons, and techniques for human-machine collaboration. So too, at a time when Chinese universities and enterprises are pursuing investment and expanding global research collaborations in such fields, it is important that their foreign partners remain cognizant of the interests and involvements of their counterparts.